Literature DB >> 23250455

[Diabetic neuropathy].

Monika Lechleitner1, Heidemarie Abrahamian, Mario Francesconi.   

Abstract

These are the guidelines for diagnosis and treatment of diabetic neuropathy. This diabetic late complication comprises a number of mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy. The position statement summarizes characteristic clinical symptoms and techniques for diagnostic assessment of diabetic neuropathy. Recommendations for the therapeutic management of diabetic neuropathy, especially for the control of pain in sensomotoric neuropathy, are provided.

Entities:  

Mesh：

Year:  2012        PMID： 23250455     DOI： 10.1007/s00508-012-0267-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  37 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Oxidative stress and autonomic nerve function in early type 1 diabetes.

Authors:  Robert Daniel Hoeldtke; Kimberly D Bryner; Knox VanDyke
Journal:  Clin Auton Res       Date:  2010-09-25       Impact factor: 4.435

Review 3.  Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Authors:  Andrea M Vincent; Brian C Callaghan; Andrea L Smith; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 4.  Experimental diabetic neuropathy: an update.

Authors:  A A Sima; K Sugimoto
Journal:  Diabetologia       Date:  1999-07       Impact factor: 10.122

5.  Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Authors:  Catherine L Martin; James Albers; William H Herman; Patricia Cleary; Barbara Waberski; Douglas A Greene; Martin J Stevens; Eva L Feldman
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

6.  Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors.

Authors:  L V van de Poll-Franse; G D Valk; C M Renders; R J Heine; J T M van Eijk
Journal:  Diabet Med       Date:  2002-09       Impact factor: 4.359

7.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

Review 8.  Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments.

Authors:  M J Mueller
Journal:  Phys Ther       Date:  1996-01

9.  A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.

Authors:  E L Feldman; M J Stevens; P K Thomas; M B Brown; N Canal; D A Greene
Journal:  Diabetes Care       Date:  1994-11       Impact factor: 19.112

10.  Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy.

Authors:  Courtney E McIlduff; Seward B Rutkove
Journal:  Ther Clin Risk Manag       Date:  2011-09-05       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.